【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 8-K Current report, item 7.01 Accession Number: 0001558370-21-009869 Act: 34 Size: 149 KB 网页链接
$Neuronetics(STIM)$ 内部交易: 2021-07-28,CFO,Furlong Stephen ,卖出,6563普通股, $13.08
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-21-006837 Size: 5 KB 网页链接
$Neuronetics(STIM)$ 内部交易: 2021-07-16,总裁 and CEO,Sullivan Keith J ,卖出,93普通股, $13.64
$Neuronetics(STIM)$ 内部交易: 2021-07-15,总裁 and CEO,Sullivan Keith J ,卖出,50893普通股, $13.46
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-21-006615 Size: 6 KB 网页链接
$Neuronetics(STIM)$ 内部交易: 2021-07-08,Sr. VP, GC, CCO and Secretary,MACAN WILLIAM ANDREW ,卖出,2591普通股, $14.61
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-21-006423 Size: 5 KB 网页链接
$Neuronetics(STIM)$ 内部交易: 2021-06-04,CFO,Furlong Stephen ,卖出,2473普通股, $15.00
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-21-005461 Size: 5 KB 网页链接